Alzheimer S Disease / MMSE-RUN and MMSE GRECO / Vascular Cognitive Impairment · Interventional Study
ClinicalTrials.gov · September 11, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registered validation study of a culturally adapted version of the Mini-Mental State Examination (MMSE-RUN) for the Reunion Island population, comparing it to the standard French version (MMSE-GRECO). The study has not yet begun recruitment and no results are available from this registry entry.
Interventional, Non Randomized, Parallel, Open label, Diagnostic purpose. Alzheimer s Disease, Vascular Cognitive Impairment; age from 60 Years; to 89 Years; accepts healthy volunteers. Intervention: Control Arm (Healthy indivuduals); Case Arm (Patients with Alzheimer's disease or vascular cog…. Compared with: MMSE-GRECO (standard French version of MMSE). n = 400. 7 sites: Reunion.
This is a registered validation study of a culturally adapted version of the Mini-Mental State Examination (MMSE-RUN) for the Reunion Island population, comparing it to the standard French version (MMSE-GRECO). The study has not yet begun recruitment and no results are available from this registry entry.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Once completed, this study may provide evidence for use of a culturally tailored cognitive screening tool in the Reunion Island population; however, results are not yet available and the clinical utility depends on how performance compares to the standard MMSE-GRECO.
This is a registered but not-yet-recruiting study describing planned validation of a culturally adapted cognitive screening tool; no results are reported.
As stated by the source record.
Quoted from the source exactly as published.
Once completed, this study may provide evidence for use of a culturally tailored cognitive screening tool in the Reunion Island population; however, results are not yet available and the clinical utility depends on how performance compares to the standard MMSE-GRECO.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07251647). This is a study registration, not published results. Lead sponsor: Centre Hospitalier Universitaire de la Réunion. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 400 participants (ESTIMATED). Conditions: Alzheimer s Disease, Vascular Cognitive Impairment. Interventions: DIAGNOSTIC_TEST: MMSE-RUN and MMSE GRECO. Primary outcome measures: Internal consistency - Cronbach's alpha , Day 1; Construct validity - Exploratory Factor Analysis , Day 1; Criterion validity - t test , Day 1. Brief summary: The Mini-Mental State Examination (MMSE) is the most widely used cognitive screening and monitoring test for neurocognitive disorders in current clinical practice. Its French version was published in 1998 by the GRECO group (MMSE-GRECO). However, some items of this French version are not adapted to local Reunionese particularities. The main objective is to propose and validate the psychometric properties of an adapted version of the MMSE, to the Reunionese culture (MMSE-RUN) in a healthy population and in a sick population (Alzheimer's Disease and Vascular Cognitive Disorder), and to compare its performance with the MMSE-GRECO.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.